Related Experiment Video

Updated: Jun 9, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.6K

The SUMO Family: Mechanisms and Implications in Thyroid Cancer Pathogenesis and Therapy

Bahejuan Jiaerken1,2, Wei Liu1, Jiaojiao Zheng1

  • 1Department of Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Biomedicines
|October 26, 2024
PubMed

Insights

Small ubiquitin-like modifiers (SUMO) regulate crucial cellular functions. Aberrant SUMOylation drives thyroid cancer, presenting new therapeutic targets for improved patient outcomes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Small ubiquitin-like modifiers (SUMO) are key regulators of post-translational modifications.
  • SUMOylation impacts protein localization, stability, and genome integrity.
  • These processes are critical in cellular functions and disease development.

Purpose of the Study:

  • To review the SUMO family, its catalytic cycle, and isoforms.
  • To highlight the role of SUMOylation in thyroid cancer biology.
  • To explore therapeutic strategies targeting SUMOylation in thyroid cancer.

Main Methods:

  • Literature review of SUMOylation pathways.
  • Analysis of SUMOylation's role in DNA repair and protein stability.
  • Examination of SUMOylation's impact on receptor activity in thyroid cancer.

Main Results:

  • Aberrant SUMOylation contributes to thyroid tumorigenesis via gene expression and immune evasion.
  • SUMOylation pathways are implicated in altered cellular functions during cancer progression.
  • Targeting SUMOylation pathways shows therapeutic potential for thyroid cancer.

Conclusions:

  • Understanding SUMOylation's role in cancer is crucial for developing novel therapies.
  • Targeting SUMOylation offers a promising avenue for treating advanced thyroid tumors.
  • Further research is needed to develop effective SUMOylation inhibitors for clinical use.
Keywords:
SUMO inhibitorSUMOylationTAK-981drug sensitivitytherapeutic targetsthyroid cancer

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.2K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.0K

Related Concept Videos

Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486